(Q33493803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

main subject

metastatic breast cancer

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Jourik A. Gietema

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

9

D T Sleijfer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

P Workman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

J E Scott

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Crawshaw

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

H J Dobbs

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

I Dennis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

N H Mulder

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

P H Willemse

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

language of work or name

English

0 references

publication date

1 September 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

641-644

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

Oral piritrexim, an effective treatment for metastatic urothelial cancer

30 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

Initial clinical studies of piritrexim.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968400

Integration of chemotherapy into combined modality treatment of solid tumors VII. Adenocarcinoma of the breast

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8353055

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW 301U), a novel lipid-soluble inhibitor of dihydrofolate reductase

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8353055

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8353055

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1993.400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

30 October 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8353055%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

PubMed publication ID

8353055

1 reference